Josef Pannee

Moelndal, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease.

Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease.

Journal: Alzheimer's research & therapy

Published: May 24, 2024

The global Alzheimer's Association round robin study on plasma amyloid β methods.

The global Alzheimer's Association round robin study on plasma amyloid β methods.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: June 24, 2021

Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.

Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.

Journal: Annals of neurology

Published: May 02, 2021

Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.

Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.

Journal: Journal of internal medicine

Published: March 06, 2021

Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.

Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.

Journal: Brain : a journal of neurology

Published: October 21, 2020

Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.

Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.

Journal: Brain : a journal of neurology

Published: June 18, 2020

Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: a pilot study.

Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: a pilot study.

Journal: Annals of clinical and translational neurology

Published: May 24, 2020

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays.

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 27, 2020

Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases.

Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases.

Journal: Journal of neurochemistry

Published: March 30, 2018

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species.

Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species.

Journal: NeuroImage. Clinical

Published: March 24, 2018

Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.

Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.

Journal: Journal of Alzheimer's disease : JAD

Published: March 06, 2018

Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements.

Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements.

Journal: Clinical chemistry and laboratory medicine

Published: February 07, 2018

Showing 1-12 of 28

Last Updated: 09/26/2026